Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system

被引:45
作者
Sahli, H
TaponBretaudiere, J
Fischer, AM
Sternberg, C
Spenlehauer, G
Verrecchia, T
Labarre, D
机构
[1] UNIV PARIS SUD,LAB BIOMAT & POLYMERES,CNRS,URA 1218 PHYSICOCHIM PHARMACOTECH BIOPHARM,F-92296 CHATENAYMALABRY,FRANCE
[2] HOP NECKER ENFANTS MALAD,HEMATOL LAB,PARIS,FRANCE
[3] RHONE POULENC RORER,DEPT PHARMACEUT SCI,VITRY SUR SEINE,FRANCE
关键词
drug carriers; nanoparticles; steric repulsion; poly(lactic acid); poly(lactic acid-co-ethylene oxide); coagulation factors;
D O I
10.1016/S0142-9612(96)00146-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
When surfactant-stabilized biodegradable poly(lactic acid) (PLA) particles are injected into rats, the rate of clearance from blood is fast. The rate can be strongly reduced by using particles made from diblock copolymers of PLA and poly(ethylene oxide) (PLA-PEO), resulting in an increased duration of contact with the components of the coagulation system. Thus, possible adverse effects such as activation of the coagulation cascade could occur. In this paper, the interactions of surfactant-stabilized PLA and PLA-PEO nanoparticle suspensions with the plasma factors of the coagulation system are presented. PLA suspensions stabilized by sodium cholate (PLA-Ch) interact with thrombin, factor V and calcium ions. Formation of complexes and aggregates is induced by addition of calcium ions to PLA-Ch suspensions in the presence or in the absence of plasma. On the contrary; PLA-PEO suspensions are remarkably inert towards the coagulation factors and calcium ions, even when cholate is present. Steric repulsion owing to the high surface density of PEO is sufficient to avoid strong interations with the proteins and formation of aggregates between particles. (C) 1997 Elsevier Science Limited. All rights reserved.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 10 条
[1]  
BALEUX B, 1972, CR ACAD SCI C CHIM, V274, P1617
[2]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[3]  
BAZILE D, 1991, Patent No. [8041, 08041]
[4]   BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES [J].
GREF, R ;
MINAMITAKE, Y ;
PERACCHIA, MT ;
TRUBETSKOY, V ;
TORCHILIN, V ;
LANGER, R .
SCIENCE, 1994, 263 (5153) :1600-1603
[5]   PROTEIN SURFACE INTERACTIONS IN THE PRESENCE OF POLYETHYLENE OXIDE .2. EFFECT OF PROTEIN SIZE [J].
JEON, SI ;
ANDRADE, JD .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1991, 142 (01) :159-166
[6]   PROTEIN SURFACE INTERACTIONS IN THE PRESENCE OF POLYETHYLENE OXIDE .1. SIMPLIFIED THEORY [J].
JEON, SI ;
LEE, JH ;
ANDRADE, JD ;
DEGENNES, PG .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1991, 142 (01) :149-158
[8]   A METHOD FOR THE ESTIMATION OF POLYETHYLENE-GLYCOL IN PLASMA-PROTEIN FRACTIONS [J].
SIMS, GEC ;
SNAPE, TJ .
ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) :60-63
[9]   NON-STEALTH (POLY(LACTIC ACID ALBUMIN)) AND STEALTH (POLY(LACTIC ACID-POLYETHYLENE GLYCOL)) NANOPARTICLES AS INJECTABLE DRUG CARRIERS [J].
VERRECCHIA, T ;
SPENLEHAUER, G ;
BAZILE, DV ;
MURRYBRELIER, A ;
ARCHIMBAUD, Y ;
VEILLARD, M .
JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) :49-61
[10]  
VITTAZ M, 1996, BIOMATERIALS, V17, P1515